Jamison Boyd
Optometrist · Tuscola, ILNPI 1326008137
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,276 of the $2,046 with a category attached, or 62.4%. Alcon accounts for 88.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $1,008 and has fallen 88.6% since, to $115 in 2025.
Across 33 payments — averaging $62.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$2K
- Regeneron Healthcare Solutions, Inc.$125
- Optos, Inc.$71
- Carl Zeiss Meditec AG$19
- Bausch & Lomb Americas Inc.$16
- Coopervision Inc.$14
What the payments were for
- Travel & lodging$1,27662%
- Food & beverage$68033%
- Gifts$191%
- Entertainment$713%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 26 | $1,802 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Optos, Inc. | 3 | $71 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Bausch & Lomb Americas Inc. | 1 | $16 |
| Coopervision Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,046 in reported general payments places this provider in the 80th percentile of 2,257 optometrist providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RocklatanNetarsudil Mesylat/Latanoprost | 18 | $6,134 |
| Latanoprost | 434 | $2,431 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 65 | $1,648 |
| Prednisolone Acetate | 17 | $506 |
| Ketorolac Tromethamine | 14 | $477 |
| Travoprost | 15 | $411 |
| Dorzolamide Hcl | 12 | $245 |
| Timolol Maleate | 33 | $212 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Tuscola
- Pamela LoweChicago$447K
- Jeffrey LewisChampaign$394K
- Adeyinka AdewaleGodfrey$391K
- Michael ChaglasianChicago$367K
- Jessilin QuintChicago$366K
- Jullian CerasuoloChicago$329K
- Steven EidenDeerfield$259K
- Peter KehoeGalesburg$167K
- Gulroop HansraDowners Grove$151K
- Treacy AdamoHinsdale$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.